Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
DYA4W9
|
|||
| Drug Name |
RXC006
|
|||
| Synonyms |
AZD5055
Click to Show/Hide
|
|||
| Drug Type |
Small molecule
|
|||
| Indication | Idiopathic pulmonary fibrosis [ICD-11: CB03.4; ICD-10: J84.1; ICD-9: 516.3] | Phase 1 | [1] | |
| Company |
Redx; AstraZeneca
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Protein-serine O-palmitoleoyltransferase porcupine (PORCN) | Target Info | Inhibitor | [2] |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT05134727) A Double-blind, Randomized, Placebo-controlled Study in Healthy Volunteers to Investigate the Safety, Tolerability and Pharmacokinetics of Oral AZD5055 Following Single and Multiple Ascending Doses. U.S.National Institutes of Health. | |||
| REF 2 | Clinical pipeline report, company report or official report of Redx | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.